10-Q Filing

ST JUDE MEDICAL INC CIK: 203077 Q2 2014

Filing Information

Form Type	10-Q
Accession Number	`0000203077-14-000010`
Period End Date	20140630
Filing Date	20140730
Fiscal Year	2014
Fiscal Period	Q2
XBRL Instance	stj-20140628.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 94 Income Statement 80 Cash Flow Statement 78 Comprehensive Income 36

Balance Sheet 94 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$51.00M	USD	Point-in-time
Accounts receivable allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$45.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.37B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.19B	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$1.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$1.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.58B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.22B	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $51 million and $45 million at June 28, 2014 and December 28, 2013, respectively	`AccountsReceivableNetCurrent`	$1.44B	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $51 million and $45 million at June 28, 2014 and December 28, 2013, respectively	`AccountsReceivableNetCurrent`	$1.42B	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Inventories	`InventoryNet`	$801.00M	USD	Point-in-time
Inventories	`InventoryNet`	$708.00M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxAssetsNetCurrent`	$231.00M	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxAssetsNetCurrent`	$229.00M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$169.00M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$178.00M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	284.56M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$4.22B	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	289.12M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$3.91B	USD	Point-in-time
Property, plant and equipment, at cost	`PropertyPlantAndEquipmentGross`	$2.86B	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	289.12M	shares	Point-in-time
Property, plant and equipment, at cost	`PropertyPlantAndEquipmentGross`	$2.80B	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	284.56M	shares	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.48B	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.39B	USD	Point-in-time
Net property, plant and equipment	`PropertyPlantAndEquipmentNet`	$1.38B	USD	Point-in-time
Net property, plant and equipment	`PropertyPlantAndEquipmentNet`	$1.41B	USD	Point-in-time
Goodwill	`Goodwill`	$3.52B	USD	Point-in-time
Goodwill	`Goodwill`	$3.48B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$868.00M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$911.00M	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxAssetsNetNoncurrent`	$102.00M	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxAssetsNetNoncurrent`	$116.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$387.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$377.00M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$10.44B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$10.25B	USD	Point-in-time
Current debt obligations	`DebtCurrent`	$62.00M	USD	Point-in-time
Current debt obligations	`DebtCurrent`	$564.00M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$247.00M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$188.00M	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$77.00M	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$72.00M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$32.00M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$46.00M	USD	Point-in-time
Employee compensation and related benefits	`EmployeeRelatedLiabilitiesCurrent`	$312.00M	USD	Point-in-time
Employee compensation and related benefits	`EmployeeRelatedLiabilitiesCurrent`	$298.00M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$654.00M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$655.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.38B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.83B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$3.64B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$3.52B	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxLiabilitiesNoncurrent`	$240.00M	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxLiabilitiesNoncurrent`	$231.00M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$706.00M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$708.00M	USD	Point-in-time
Total liabilities	`Liabilities`	$6.41B	USD	Point-in-time
Total liabilities	`Liabilities`	$5.84B	USD	Point-in-time
Commitments and Contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock ($1.00 par value; 25,000,000 shares authorized; none outstanding)	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock ($1.00 par value; 25,000,000 shares authorized; none outstanding)	`PreferredStockValue`	-	USD	Point-in-time
Common stock ($0.10 par value; 500,000,000 shares authorized; 284,564,301 and 289,117,352 shares issued and outstanding at June 28, 2014 and December 28, 2013, respectively)	`CommonStockValueOutstanding`	$28.00M	USD	Point-in-time
Common stock ($0.10 par value; 500,000,000 shares authorized; 284,564,301 and 289,117,352 shares issued and outstanding at June 28, 2014 and December 28, 2013, respectively)	`CommonStockValueOutstanding`	$29.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$220.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$18.00M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$3.94B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$3.90B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$21.00M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$46.00M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$6.00M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$46.00M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$37.00M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$56.00M	USD	Point-in-time
Total shareholders' equity before noncontrolling interest	`StockholdersEquity`	$3.98B	USD	Point-in-time
Total shareholders' equity before noncontrolling interest	`StockholdersEquity`	$4.23B	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$56.00M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$173.00M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.09B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.08B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.04B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.40B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$10.44B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$10.25B	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
Net sales	`SalesRevenueNet`	$2.74B	USD	2 Qtrs
Net sales	`SalesRevenueNet`	$2.81B	USD	2 Qtrs
Net sales	`SalesRevenueNet`	$1.40B	USD	1 Quarter
Net sales	`SalesRevenueNet`	$1.45B	USD	1 Quarter
Cost of sales before special charges	`CostOfSalesBeforeSpecialCharges`	$740.00M	USD	2 Qtrs
Cost of sales before special charges	`CostOfSalesBeforeSpecialCharges`	$407.00M	USD	1 Quarter
Cost of sales before special charges	`CostOfSalesBeforeSpecialCharges`	$381.00M	USD	1 Quarter
Cost of sales before special charges	`CostOfSalesBeforeSpecialCharges`	$789.00M	USD	2 Qtrs
Special charges	`SpecialCharges`	$26.00M	USD	1 Quarter
Special charges	`SpecialCharges`	$19.00M	USD	2 Qtrs
Special charges	`SpecialCharges`	$1.00M	USD	1 Quarter
Special charges	`SpecialCharges`	$27.00M	USD	2 Qtrs
Total cost of sales	`CostOfGoodsSold`	$759.00M	USD	2 Qtrs
Total cost of sales	`CostOfGoodsSold`	$816.00M	USD	2 Qtrs
Total cost of sales	`CostOfGoodsSold`	$382.00M	USD	1 Quarter
Total cost of sales	`CostOfGoodsSold`	$433.00M	USD	1 Quarter
Gross profit	`GrossProfit`	$2.00B	USD	2 Qtrs
Gross profit	`GrossProfit`	$1.02B	USD	1 Quarter
Gross profit	`GrossProfit`	$1.01B	USD	1 Quarter
Gross profit	`GrossProfit`	$1.98B	USD	2 Qtrs
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$489.00M	USD	1 Quarter
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$957.00M	USD	2 Qtrs
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$523.00M	USD	1 Quarter
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$988.00M	USD	2 Qtrs
Research and development expense	`ResearchAndDevelopmentExpense`	$348.00M	USD	2 Qtrs
Research and development expense	`ResearchAndDevelopmentExpense`	$333.00M	USD	2 Qtrs
Research and development expense	`ResearchAndDevelopmentExpense`	$178.00M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$173.00M	USD	1 Quarter
Special charges	`RestructuringSettlementAndImpairmentProvisions`	$58.00M	USD	2 Qtrs
Special charges	`RestructuringSettlementAndImpairmentProvisions`	$102.00M	USD	2 Qtrs
Special charges	`RestructuringSettlementAndImpairmentProvisions`	$77.00M	USD	1 Quarter
Special charges	`RestructuringSettlementAndImpairmentProvisions`	$25.00M	USD	1 Quarter
Operating profit	`OperatingIncomeLoss`	$590.00M	USD	2 Qtrs
Operating profit	`OperatingIncomeLoss`	$601.00M	USD	2 Qtrs
Operating profit	`OperatingIncomeLoss`	$289.00M	USD	1 Quarter
Operating profit	`OperatingIncomeLoss`	$282.00M	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-41.00M	USD	2 Qtrs
Other expense, net	`OtherNonoperatingIncomeExpense`	$-231.00M	USD	2 Qtrs
Other expense, net	`OtherNonoperatingIncomeExpense`	$-183.00M	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-21.00M	USD	1 Quarter
Earnings before income taxes and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$268.00M	USD	1 Quarter
Earnings before income taxes and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$560.00M	USD	2 Qtrs
Earnings before income taxes and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$359.00M	USD	2 Qtrs
Earnings before income taxes and noncontrolling interest	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$99.00M	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-8.00M	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$22.00M	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$30.00M	USD	2 Qtrs
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$75.00M	USD	2 Qtrs
Net earnings before noncontrolling interest	`ProfitLoss`	$329.00M	USD	2 Qtrs
Net earnings before noncontrolling interest	`ProfitLoss`	$107.00M	USD	1 Quarter
Net earnings before noncontrolling interest	`ProfitLoss`	$485.00M	USD	2 Qtrs
Net earnings before noncontrolling interest	`ProfitLoss`	$246.00M	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-8.00M	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-24.00M	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-9.00M	USD	2 Qtrs
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-34.00M	USD	2 Qtrs
Net earnings attributable to St. Jude Medical, Inc.	`NetIncomeLoss`	$270.00M	USD	1 Quarter
Net earnings attributable to St. Jude Medical, Inc.	`NetIncomeLoss`	$338.00M	USD	2 Qtrs
Net earnings attributable to St. Jude Medical, Inc.	`NetIncomeLoss`	$519.00M	USD	2 Qtrs
Net earnings attributable to St. Jude Medical, Inc.	`NetIncomeLoss`	$115.00M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$1.83	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$1.19	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$0.41	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.95	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$1.80	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.40	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$1.18	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.93	USD	1 Quarter
Cash dividends declared per share:	`CommonStockDividendsPerShareDeclared`	$0.50	USD	2 Qtrs
Cash dividends declared per share:	`CommonStockDividendsPerShareDeclared`	$0.25	USD	1 Quarter
Cash dividends declared per share:	`CommonStockDividendsPerShareDeclared`	$0.54	USD	2 Qtrs
Cash dividends declared per share:	`CommonStockDividendsPerShareDeclared`	$0.27	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	284.60M	shares	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	284.30M	shares	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	283.90M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	284.20M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	286.70M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	289.10M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	288.90M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	287.10M	shares	2 Qtrs

Cash Flow Statement 78 line items

Line Item	Tag	Value	Unit	Period
Net earnings before noncontrolling interest	`ProfitLoss`	$246.00M	USD	1 Quarter
Net earnings before noncontrolling interest	`ProfitLoss`	$329.00M	USD	2 Qtrs
Net earnings before noncontrolling interest	`ProfitLoss`	$107.00M	USD	1 Quarter
Net earnings before noncontrolling interest	`ProfitLoss`	$485.00M	USD	2 Qtrs
Depreciation of property, plant and equipment	`Depreciation`	$98.00M	USD	2 Qtrs
Depreciation of property, plant and equipment	`Depreciation`	$110.00M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$42.00M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$40.00M	USD	2 Qtrs
Amortization of debt premium, net	`AmortizationOfDebtDiscountPremium`	$-1.00M	USD	2 Qtrs
Amortization of debt premium, net	`AmortizationOfDebtDiscountPremium`	$-3.00M	USD	2 Qtrs
Contingent consideration fair value adjustment	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$9.00M	USD	2 Qtrs
Contingent consideration fair value adjustment	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	-	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$33.00M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$34.00M	USD	2 Qtrs
Excess tax benefits from stock issued under employee stock plans	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$12.00M	USD	2 Qtrs
Excess tax benefits from stock issued under employee stock plans	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$1.00M	USD	2 Qtrs
Gain on sale of investment	`AvailableForSaleSecuritiesGrossRealizedGains`	$5.00M	USD	2 Qtrs
Gain on sale of investment	`AvailableForSaleSecuritiesGrossRealizedGains`	-	USD	2 Qtrs
Loss on retirement of long-term debt	`GainsLossesOnExtinguishmentOfDebt`	$-161.00M	USD	2 Qtrs
Loss on retirement of long-term debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Deferred income taxes, net	`DeferredIncomeTaxesAndTaxCredits`	$4.00M	USD	2 Qtrs
Deferred income taxes, net	`DeferredIncomeTaxesAndTaxCredits`	$-20.00M	USD	2 Qtrs
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$40.00M	USD	2 Qtrs
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$14.00M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$71.00M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$14.00M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$37.00M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$93.00M	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$-15.00M	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$15.00M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-48.00M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$5.00M	USD	2 Qtrs
Income taxes payable	`IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable`	$-160.00M	USD	2 Qtrs
Income taxes payable	`IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable`	$21.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$396.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$564.00M	USD	2 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$91.00M	USD	2 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$117.00M	USD	2 Qtrs
Proceeds from sale of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesEquity`	$6.00M	USD	2 Qtrs
Proceeds from sale of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesEquity`	$4.00M	USD	2 Qtrs
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	2 Qtrs
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$13.00M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-124.00M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-87.00M	USD	2 Qtrs
Proceeds from exercise of stock options and stock issued, net	`ProceedsFromStockOptionsExercised`	$78.00M	USD	2 Qtrs
Proceeds from exercise of stock options and stock issued, net	`ProceedsFromStockOptionsExercised`	$102.00M	USD	2 Qtrs
Excess tax benefits from stock issued under employee stock plans	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$1.00M	USD	2 Qtrs
Excess tax benefits from stock issued under employee stock plans	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$12.00M	USD	2 Qtrs
Common stock repurchased, including related costs	`PaymentsForRepurchaseOfCommonStock`	$476.00M	USD	2 Qtrs
Common stock repurchased, including related costs	`PaymentsForRepurchaseOfCommonStock`	$609.00M	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$139.00M	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$149.00M	USD	2 Qtrs
Issuances (payments) of commercial paper borrowings, net	`ProceedsFromRepaymentsOfShortTermDebt`	$622.00M	USD	2 Qtrs
Issuances (payments) of commercial paper borrowings, net	`ProceedsFromRepaymentsOfShortTermDebt`	$-318.00M	USD	2 Qtrs
Borrowings under debt facilities	`ProceedsFromIssuanceOfLongTermDebt`	$2.09B	USD	2 Qtrs
Borrowings under debt facilities	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	2 Qtrs
Payments under debt facilities	`RepaymentsOfLongTermDebt`	$1.20B	USD	2 Qtrs
Payments under debt facilities	`RepaymentsOfLongTermDebt`	-	USD	2 Qtrs
Purchase of shares from noncontrolling interest	`PaymentsToMinorityShareholders`	$344.00M	USD	2 Qtrs
Purchase of shares from noncontrolling interest	`PaymentsToMinorityShareholders`	-	USD	2 Qtrs
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-167.00M	USD	2 Qtrs
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-12.00M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-269.00M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-234.00M	USD	2 Qtrs
Effect of currency exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-1.00M	USD	2 Qtrs
Effect of currency exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-12.00M	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$26.00M	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$207.00M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.22B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.58B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.37B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.19B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.37B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.19B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.58B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.22B	USD	Point-in-time
Additions in noncontrolling ownership interest	`NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1`	-	USD	2 Qtrs
Additions in noncontrolling ownership interest	`NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1`	$249.00M	USD	2 Qtrs

Comprehensive Income 36 line items

Line Item	Tag	Value	Unit	Period
Net earnings before noncontrolling interest	`ProfitLoss`	$246.00M	USD	1 Quarter
Net earnings before noncontrolling interest	`ProfitLoss`	$329.00M	USD	2 Qtrs
Net earnings before noncontrolling interest	`ProfitLoss`	$107.00M	USD	1 Quarter
Net earnings before noncontrolling interest	`ProfitLoss`	$485.00M	USD	2 Qtrs
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$1.00M	USD	2 Qtrs
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$1.00M	USD	1 Quarter
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$2.00M	USD	1 Quarter
Unrealized gain on available-for-sale securities	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$1.00M	USD	2 Qtrs
Unrealized gain on derivative financial instruments	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	-	USD	2 Qtrs
Unrealized gain on derivative financial instruments	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	-	USD	1 Quarter
Unrealized gain on derivative financial instruments	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	-	USD	1 Quarter
Unrealized gain on derivative financial instruments	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$3.00M	USD	2 Qtrs
Reclassification of realized gain to net earnings on available-for-sale securities	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	-	USD	2 Qtrs
Reclassification of realized gain to net earnings on available-for-sale securities	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	-	USD	1 Quarter
Reclassification of realized gain to net earnings on available-for-sale securities	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$3.00M	USD	1 Quarter
Reclassification of realized gain to net earnings on available-for-sale securities	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$3.00M	USD	2 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-10.00M	USD	2 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-14.00M	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-20.00M	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-41.00M	USD	2 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-15.00M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-19.00M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-9.00M	USD	2 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-40.00M	USD	2 Qtrs
Total comprehensive income before noncontrolling interest	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$289.00M	USD	2 Qtrs
Total comprehensive income before noncontrolling interest	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$227.00M	USD	1 Quarter
Total comprehensive income before noncontrolling interest	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$476.00M	USD	2 Qtrs
Total comprehensive income before noncontrolling interest	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$92.00M	USD	1 Quarter
Total comprehensive loss attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-9.00M	USD	2 Qtrs
Total comprehensive loss attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-34.00M	USD	2 Qtrs
Total comprehensive loss attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-24.00M	USD	1 Quarter
Total comprehensive loss attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-8.00M	USD	1 Quarter
Total comprehensive income attributable to St. Jude Medical, Inc.	`ComprehensiveIncomeNetOfTax`	$510.00M	USD	2 Qtrs
Total comprehensive income attributable to St. Jude Medical, Inc.	`ComprehensiveIncomeNetOfTax`	$251.00M	USD	1 Quarter
Total comprehensive income attributable to St. Jude Medical, Inc.	`ComprehensiveIncomeNetOfTax`	$100.00M	USD	1 Quarter
Total comprehensive income attributable to St. Jude Medical, Inc.	`ComprehensiveIncomeNetOfTax`	$298.00M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.